5 Results for "

PI3K/mTOR-IN-21

" in MedChemExpress (MCE) Product Catalog:
Products (5)

5 Results for "PI3K/mTOR-IN-21" in MCE Product Catalog:

Cat. No.: HY-185456
Target:  

ADC Payloads PI3K mTOR

Research Areas:  

Cancer

PI3K/mTOR-IN-21 is a potent dual PI3K/mTOR inhibitor that exhibits favorable overall properties.
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-11042
CAS No.: 1032754-81-6
Purity:  98.75%
Target:  

PI3K mTOR

Research Areas:  

Cancer

GNE-477 is a potent and efficacious dual PI3K (IC50=4 nM)/mTOR(Ki=21 nM) inhibitor.
loading...
    loading...
Cat. No.: HY-185457
Research Areas:  

Cancer

BrAC-GGFG-Aminal-PI3K/mTOR-IN-21 is a conjugate of PI3K/mTOR-IN-21 (HY-185456) and Linker.
loading...
    loading...
Cat. No.: HY-11042R
CAS No.: 1032754-81-6
Research Areas:  

Cancer

GNE-477 (Standard) is the analytical standard of GNE-477 (HY-11042). This product is intended for research and analytical applications. GNE-477 is a potent and efficacious dual PI3K (IC50=4 nM)/mTOR(Ki=21 nM) inhibitor.
loading...
    loading...
Cat. No.: HY-185460
Research Areas:  

Cancer

Pertuzumab-LD3 is a humanized antibody-drug conjugate (ADC) targeting HER2. Pertuzumab-LD3 consists of the anti-HER2 humanized IgG1 monoclonal antibody Pertuzumab (HY-P9912), the cleavable linker Gly-Gly-Phe-Gly (HY-P3669), and the PI3K/mTOR-IN-21 (HY-185456) payload. Pertuzumab-LD3 can be used in research on metastatic HER2-positive breast cancer.
loading...
    loading...